Privium Fund Management B.V. Bio N Tech Se Transaction History
Privium Fund Management B.V.
- $551 Million
- Q3 2025
A detailed history of Privium Fund Management B.V. transactions in Bio N Tech Se stock. As of the latest transaction made, Privium Fund Management B.V. holds 19,000 shares of BNTX stock, worth $1.96 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
19,000
Previous 10,987
72.93%
Holding current value
$1.96 Million
Previous $1.17 Million
60.22%
% of portfolio
0.34%
Previous 0.25%
Shares
2 transactions
Others Institutions Holding BNTX
# of Institutions
318Shares Held
43.6MCall Options Held
1.15MPut Options Held
1.36M-
Baillie Gifford & CO7.88MShares$812 Million0.61% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.83MShares$498 Million0.29% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.23MShares$436 Million1.69% of portfolio
-
Primecap Management CO Pasadena, CA3.87MShares$399 Million0.3% of portfolio
-
Dodge & Cox San Francisco, CA3.65MShares$376 Million0.21% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...